1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow dapirolizumab pegol: new trials by email Literature Review of dapirolizumab pegol trials Research Report on dapirolizumab pegol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus Placebo, Dapirolizumab pegol (DZP) - Systemic Lupus Erythematosus (SLE) | Phase 2 | Completed | UCB Biopharma S.P.R.L. | 182 | 2016-06-02 | 2021-06-30 |
Lupus Erythematosus, Systemic (1)
Bulgaria (1) · Chile (1) · Colombia (1) · Germany (1) · Hungary (1) · Mexico (1) · Peru (1) · Poland (1) · Romania (1) · Russia (1) · Spain (1) · Ukraine (1) · United States (1)
2015 (1)